50 Top Stock Picks That Billionaires Love
Cisco Systems
Technology has always been evolving, and the demand for advanced gadgets has increased in the past decade. So it isn’t surprising to know that big companies and notable names have put their money on brands in Silicon Valley, including Cisco Systems.
London-based advisory Generation Investment Management, which was founded by its chair ex-Vice President Al Gore, has poured in cash for 18 million shares of the tech company in the third quarter of 2020. Founded by computer scientists Sandy Lerner and Leonard Bosack in 1984, Cisco has a market value of around $175 billion.
Delta Air Lines
The airline economy has suffered a major blow because of the COVID-19 pandemic, and even now that travel orders have relaxed, the industry has yet to rise from the debris. So why are billionaires still spewing money on this sector? PAR Capital Management, for instance, has increased its Delta Air Lines shares by 9,450, now totaling over 3.5 million.
Now we’re wondering if this boost may have fueled DAL’s plans to shell out $12 billion for infrastructure in the United States. Nonetheless, with the COVID-19 vaccines rolling out, it seems that tourism-related sectors will get to soar anew.
Barrick Gold
Interestingly, New South Wales, Australia-based company Platinum Investment Management has invested in another element, gold—that is, Barrick Gold, a mining brand whose list of investors includes Berkshire Hathaway CEO Warren Buffett. The nonagenarian had put a significant amount on the brand in 2020 for over 20 million shares.
In the third quarter, Platinum has increased its stocks to 2.7 million. In February 2021, Barrick Gold reportedly had other earnings beat for the sixth time despite the pandemic. The Toronto-based company said its shares increased, and to accomplish this feat, it decreased costs and increased output.
Johnson & Johnson
Baby necessities and medical needs are often associated with New Jersey-based Johnson & Johnson, making it a very profitable brand. Many investors know this, including hedge fund Levin Capital Strategies, which has been buying shares since 2006. The medical company accounts for five percent of the New York firm’s portfolio despite only raising its shares by one percent in the third quarter of 2020.
Meanwhile, Johnson & Johnson’s vaccine will be up for discussion before February 2021 ends, as vaccine experts weigh in if the single-dose vaccine can be administered for emergency use. The company has yet to receive authorization from the government.